Neurogenic regulation of coronary vasomotor tone

Area of Science:

• Cardiovascular Physiology
• Autonomic Nervous System
• Vascular Pharmacology

Background:

• Controversies exist regarding acetylcholine's effects on coronary blood flow.
• Species differences, endothelial role, and acetylcholine's chronotropic/inotropic effects complicate interpretations.
• Human studies suggest epicardial artery dilation and atherosclerotic segment constriction by acetylcholine.

Purpose of the Study:

• To clarify the role of acetylcholine and adrenergic receptors in regulating coronary blood flow.
• To investigate the mechanisms underlying acetylcholine-induced coronary vascular responses.
• To determine the involvement of these mechanisms in myocardial ischemia.

Main Methods:

• Review of existing literature on acetylcholine and adrenergic receptor function in coronary circulation.
• Analysis of studies examining vascular smooth muscle responses to acetylcholine.
• Investigation of beta- and alpha-adrenergic receptor roles in coronary vasoregulation and ischemia.

Main Results:

• Acetylcholine predominantly dilates intact human epicardial coronary arteries but constricts atherosclerotic segments.
• Beta-adrenergic receptors mediate coronary dilation but are less significant during sympathetic activation.
• Alpha-adrenergic constriction of coronary resistance vessels can precipitate myocardial ischemia, particularly in effort angina.

Conclusions:

• Acetylcholine's net effect on coronary blood flow is complex and context-dependent.
• While vagal initiation of ischemia is not evident, alpha-adrenergic mechanisms can precipitate myocardial ischemia.
• Understanding these pathways is crucial for managing ischemic heart disease.